HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

H Walczak Selected Research

Caspases

10/2014Bortezomib sensitises TRAIL-resistant HPV-positive head and neck cancer cells to TRAIL through a caspase-dependent, E6-independent mechanism.
6/2010Novel SMAC-mimetics synergistically stimulate melanoma cell death in combination with TRAIL and Bortezomib.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


H Walczak Research Topics

Disease

15Neoplasms (Cancer)
12/2019 - 06/2000
7Necrosis
11/2014 - 04/2000
3Melanoma (Melanoma, Malignant)
07/2013 - 05/2008
2Head and Neck Neoplasms (Head and Neck Cancer)
11/2014 - 10/2014
2Squamous Cell Carcinoma of Head and Neck
11/2014 - 10/2014
2Inflammation (Inflammations)
11/2014 - 11/2013
2Hepatocellular Carcinoma (Hepatoma)
11/2014 - 07/2004
2Infections
06/2013 - 12/2001
2Glioma (Gliomas)
02/2008 - 07/2001
1Hepatitis
11/2014
1Chronic Hepatitis (Chronic Active Hepatitis)
11/2014
1Liver Diseases (Liver Disease)
11/2014
1Liver Failure
11/2014
1Lung Neoplasms (Lung Cancer)
03/2014
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2014
1Reperfusion Injury
11/2013
1Human Influenza (Influenza)
06/2013
1Carcinoma (Carcinomatosis)
04/2008
1Glioblastoma (Glioblastoma Multiforme)
02/2008
1Lymphoma (Lymphomas)
03/2002
1Adenocarcinoma
07/2001
1Renal Cell Carcinoma (Grawitz Tumor)
11/2000
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
02/2000
1Burkitt Lymphoma (Burkitt's Lymphoma)
01/2000

Drug/Important Bio-Agent (IBA)

10LigandsIBA
11/2014 - 06/2000
7Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2014 - 06/2000
6Caspase 8 (Caspase-8)IBA
11/2014 - 01/2000
5Death Domain ReceptorsIBA
05/2016 - 01/2000
5Proteins (Proteins, Gene)FDA Link
11/2014 - 02/2008
5TNF-Related Apoptosis-Inducing LigandIBA
09/2014 - 04/2000
4Fas Ligand Protein (Fas Ligand)IBA
05/2008 - 07/2001
3Pharmaceutical PreparationsIBA
07/2013 - 06/2000
3NF-kappa B (NF-kB)IBA
11/2008 - 04/2000
2Interleukin-4 (Interleukin 4)IBA
12/2019 - 04/2008
2Antineoplastic Agents (Antineoplastics)IBA
11/2014 - 10/2014
2Phosphotransferases (Kinase)IBA
11/2014 - 02/2008
2CaspasesIBA
10/2014 - 06/2010
2Bortezomib (Velcade)FDA Link
10/2014 - 06/2010
1Caspase 10IBA
11/2014
1BH3 Interacting Domain Death Agonist ProteinIBA
11/2014
1Type I Tumor Necrosis Factor ReceptorsIBA
11/2014
1Proteasome Endopeptidase Complex (Proteasome)IBA
10/2014
1Cyclin-Dependent Kinase 9IBA
03/2014
1N- (5- (((5- (1,1- dimethylethyl)- 2- oxazolyl)methyl)thio)- 2- thiazolyl)- 4- piperidinecarboxamideIBA
03/2014
1Cisplatin (Platino)FDA LinkGeneric
07/2013
1Poly I-CIBA
06/2013
1Toll-Like Receptor 3IBA
06/2013
1Small Interfering RNA (siRNA)IBA
02/2008
1Glucose (Dextrose)FDA LinkGeneric
02/2008
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
02/2008
1DNA (Deoxyribonucleic Acid)IBA
01/2008
1Fas-Associated Death Domain Protein (Fas-Associating Protein with Death Domain)IBA
02/2007
1factor AIBA
02/2007
1butyl phosphorotrithioate (DEF)IBA
02/2007
1SuperantigensIBA
03/2002
1Nitric Oxide (Nitrogen Monoxide)FDA Link
03/2002
1AntigensIBA
03/2002
1Antiviral Agents (Antivirals)IBA
12/2001
1Protein Kinase CIBA
07/2001
1Lomustine (CCNU)FDA Link
07/2001
1Cytochromes c (Cytochrome c)IBA
07/2001
1TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
07/2001
1Topotecan (Hycamtin)FDA LinkGeneric
11/2000
1Etoposide (VP 16)FDA LinkGeneric
06/2000
1CytokinesIBA
04/2000
1CASP8 and FADD-Like Apoptosis Regulating Protein (FLIP-S)IBA
02/2000

Therapy/Procedure

8Therapeutics
05/2016 - 04/2001
4Drug Therapy (Chemotherapy)
10/2014 - 06/2000
1Transplantation
11/2013
1Chemoradiotherapy
07/2001
1Aftercare (After-Treatment)
02/2000